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The 4-Hydroxycoumarin derivatives are known to show a broad spectrum of pharmacological 
applications. In this paper we are reporting the synthesis of a new series of 4-Hydroxycoumarin 
derivatives synthesized through Knovenegal condensation; they were characterized by using UV-Vis, 
FT-IR, NMR spectroscopies. The synthesized compounds were evaluated for antibacterial activity 
against Staphylococcus aureus and Salmonella typhimurium strains. The compounds (2), (3) and (8) 
showed favorable antibacterial activity with zone of inhibitions 26.5± 0.84, 26.0 ± 0.56 and 26.0 ± 
0.26 against Staphylococcus aureus (Gram-positive) respectively. However, the compounds (5) and 
(9) were found more active with 19.5 ± 0.59 and 19.5 ± 0.32 zone of inhibitions against Salmonella 
typhimurium (Gram-negative). Whereas, in urease inhibition assay, none of the synthesized 
derivatives showed significant anti-urease activity; although, in carbonic anhydrase-II inhibition 
assay, the compound (2) and (6) showed enzyme inhibition activity with IC
50
 values 263±0.3 and 
456±0.1, respectively. 
Keywords: 4-Hydroxycoumarin. Anti-urease. Carbonic anhydrase. Aldehydes. Antibacterial.
INTRODUCTION
The derivatives of 4-Hydroxycoumarin (Figure 
1) are of great interest due to their broad spectrum of 
pharmacological activities including antioxidant (Jung, 
Park, 2009), anti-allergy (Lee et al., 2004), antiviral (Yu 
et al., 2003), anti-diabetic (Kontogiorgis, Hadjipavlou-
Litina, 2005), anti-HIV (Tosun et al., 2008), anticonvulsant 
(Sashidhara et al., 2010), anti-tubercular (Jin, Chen, 
Zhu, 2007), anti-hyperlipidmeic (Hamdi et al., 2011), 
rodenticidal (Khan et al., 2004) and antifungal (Gao et 
al., 2010). Some of the 4-Hydroxycoumarin derivatives 
such as warfarin, coumatetralyl, bromadiolone, 
flocoumafen and brodifacoum are known due to their 
anticoagulant (Stanchev et al., 2009; Trivedi et al., 2007), 
anti-inflammatory (Cardoso et al., 2011), antipyretic, 
antibacterial (Jung et al., 2004; Manolov, Maichle-
Moessmer, Danchev, 2006) antiviral as well as anticancer 
activities (Inoue et al., 1994; Kostova et al., 2001). The 
coumarin derivatives are also used in medicines for 
treatment of renal stones. These stones are known to 
form by the decomposition of urea to carbon dioxide 
and ammonia causing urological diseases (Gunnewegh, 
Hoefnagel, van Bekkum, 1995; De la Hoz, Moreno, 
Vazquez, 1999). The coumarin derivatives are also 
reported for the inhibition of carbonic anhydrase enzyme 
which are involved in osteoporosis and malfunctioning 
of the human kidneys (Stefanou et al., 2011). Therefore, 
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synthesizing new derivatives of 4-Hydroxycoumarin 
may lead towards the discovery of some new potent 
compounds which can prove to be beneficial while 
developing medicines of above mentioned diseases.
The organic compounds such as 4-Hydroxycoumarin 
having active methylene group can undergo Knovenegal 
condensation with compounds possessing carbonyl 
functionality (Kidwai et al., 2007). Knovenegal 
condensation is a known method for the formation of 
carbon to carbon double bond. Here, in this paper, we are 
reporting new derivatives of 4-Hydroxycoumarin which 
are synthesized through Knovenegal condensation. 
FIGURE 1 - Structure of 4-Hydroxycoumarin.
MATERIAL AND METHODS
The UV-Vis spectra of synthesized 
4-Hydroxycoumarin derivatives (1-9) were recorded 
on PG instrument T80 + UV-Vis Spectrophotometer 
ranging from 200 nm to 800 nm. The FT-IR analysis of 
compounds was performed on PerkinElmer Spectrum 
100 FT-IR Spectrometer. The 1H NMR δ (ppm) 
spectra were recorded in CDCl3/DMSO-d6 by using 
Bruker AM-400 & 500 MHz NMR spectrometer. All 
the chemicals and solvents used in this research were 
purchased from SigmaAldrich®/Fluka and were of 
analytical grade. Chemicals/solvents were used without 
any further purification, until and unless mentioned.
Synthesis of 4-hydroxy-6-nitrocoumarin (1)
To a pre-cooled sulfuric acid (10 mL), 
4-Hydroxycoumarin (3.08 mmol; 1.0 equiv.) and sodium 
nitrate (4.60 mmol: 1.2 equiv.) were added. The resulting 
mixture was stirred at 0 °C for 1.0 h. The reaction progress 
was monitored on TLC (dichloromethane:methanol 
4:1). On completion of the reaction, the reaction mixture 
was poured on ice-cooled water. The crude product 
precipitated out and was filtered; subsequently, the 
product was re-crystallized using a mixture of EtOAc/n-
hexane (7:3) to obtain the final product as a white solid 
(Huang et al., 2007).
General procedure for the synthesis of 
4-hydroxy-6-nitrocoumarin derivatives (2-9)
The derivatives of 4-Hydroxycoumarin (2-9) were 
synthesized by the reaction of (1) (0.48 mmol; 1.0 
equiv.) with different substituted aromatic aldehydes 
(0.48 mmol; 1.0 equiv.) in 15 mL of ethanol. The 
reaction mixture was refluxed for 20-30 h as shown 
in (Scheme 1). Reaction progress was monitored by 
TLC (dichloromethane:methanol 4:1). Each product 
precipitated out as a solid which was subsequently filtered 
and washed with saturated solution of sodium bisulphite 
(3x) to get pure production moderate to good yield.
SCHEME 1 - General synthetic route for 4-Hydroxycoumarin derivatives.
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Antibacterial activity
The synthesized derivatives of 4-Hydroxycoumarin 
were subjected to an antimicrobial activity analysis by 
using agar well diffusion method (Patonay et al., 1984). 
During this study, two clinically isolated bacterial strains 
from the blood of diseased patients were used. One 
strain was Staphylococcus aureus (S. aureus; Gram-
positive) which can cause food poisoning, skin infection, 
respiratory tract infections. Whereas, the second strain 
was Salmonella typhimurium (S. typhimurium; Gram-
negative) which is known to cause typhoid fever, 
weakness, stomachache, headache or loss of appetite. 
The ciprofloxacin was used as a positive control (8.3 
µg/µL in DMSO). The DMSO was used as a negative 
control. In this method, agar plates were prepared by 
pouring about 10 mL ager solution in each petri dish 
(94 mm x 16 mm). Next, the swishing of ager filled petri 
dish was carried out in order to smooth the surface. The 
inhibition zones were measured in millimeters (mm) by 
using a ruler. These plates were inoculated with bacterial 
strains under sterilized conditions and wells were filled 
with test samples (compound 1-9), which were prepared 
by dissolving 1 mg of each sample in 120 µL of DMSO. 
Specified wells were also filled with positive as well as 
negative controls. The 30 µL of each sample along with 
positive and negative controls were added to each well 
followed by incubation of petri dishes at 37 °C for 20-24 




The reaction mixture containing 25 µL of enzyme 
(jack bean urease) solution, 55 µL of buffer solution 
(containing 100 mM urea) and 5 µL of test compound 
(0.5 mM) were incubated in a 96-well flat bottom plate 
at 30 °C for 15 min. Urease inhibition was measured by 
indophenol method, described by Weatherburn (Arfan 
et al., 2010). Briefly, 45 µL of each phenol reagent 
which contains [1% (w/v) phenol and 0.005% (w/v) 
sodium nitroprussside], and the 70 µL of alkali reagent 
containing [0.5% (w/v) sodium hydroxide and 0.1% 
NaOCl) were added to the each well. The increasing 
change in absorbance was measured at 630 nm after 
50 min by using a microplate reader SpectraMax, M2 
(Molecular Device, CA, USA). All the reactions were 
repeated three times in a final volume of 200 µL. The 
entire assay was accomplished at pH 6.8. 
The percentage inhibition was measured by using 
the above equation. In this method thiourea was used as 
the reference standard inhibitor of urease activity.
Carbonic anhydrase inhibition assay 
The hydrolysis of 4-nitrophenyl acetate (4-NPA) 
produces 4-nitrophenol and CO2. The reaction was 
examined by quantifying the formation of a yellow 
colored compound, 4-nitrophenol at a wavelength of 400 
nm. In this experiment, HEPES-tris buffer was used at a 
final concentration of 20 mM at pH 7.4. The total reaction 
volume of 200 µL was made by adding 140 µL of the 
HEPES-tris, 20 µL of test compounds (0.5 mM) dissolved 
in DMSO, 20 µL of purified bovine erythrocyte CA-II 
(0.1 mg/mL) prepared in de-ionized water, and 20 µL of 
4-NPA (0.7 mM) dissolved in ethanol. As a control, 20 
µL of DMSO was used instead of test compound. Initially 
test compounds were incubated in a 96-well flat bottom 
plate for a period of 15 min with the enzyme. The rate 
of product formation was measured by the addition of 20 
µL substrate at 25 °C for a period of 30 min with regular 
interval of 1 min. SpectraMax M2 (Molecular Device, 
CA, USA) was used for the measurement of product 
(4-nitrophenol) formation in triplicate, at a wavelength 
of 400 nm (Supuran, Scozzafava, Casini, 2003).
RESULTS AND DISCUSSION
4-Hydroxy-6-nitrocoumarin (1)
The compound (1) was obtained by the nitration of 
4-Hydroxycoumarin using sodium nitrate and sulfuric 
acid. Yield: 70%; Rf; 0.5 (dichloromethane:methanol 
4:1); m.p.: 252-254 °C; UV-Vis (DMF) λmax: 315 nm; FT-
IR (KBr) ν: 3500, 1753, 1608, 1515, 1343 cm-1, 1H NMR 
(400 MHz, CDCl3) δ:8.67 (dd, J = 4, 8 Hz, 1H at C 1), 
7.56 (d, J = 8 Hz, 1H at C 2), 9.07 (d, J = 4 Hz, 1H at C 5), 
5.85 (s, 1H at C 9), 15.98 (s, 1H at C 10). The product was 
obtained in comparatively good yield with a considerable 
range of melting point and maximum absorbance at 315 
nm. The presence of nitrogen containing functional 
group has been confirmed by the appearance of signals 
in FT-IR at 1340 cm-1 and 1524 cm-1. This confirms that 
a successful nitrogen containing coumarin has been 
synthesized. Furthermore, the possibility of nitration 
occurring at alkene functionality has been ruled out by 
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the presence of stretching vibration of the alkene group 
at 1608 cm-1 which verifies that the alkene functionality 
is intact in the synthesized molecule. Similarly, the 
presence of vibration frequencies at 3500 cm-1 and 
1753 cm-1 clearly confirm the presence of hydroxyl 
as well as carbonyl functionalities in the compound, 
respectively. The appearance of singlet at 15.98 in 
1HNMR, taken in CDCl3, also confirms the presence 
of hydroxyl groups, whereas appearance of a downfield 
singlet at 5.85 shows the existence of alkene group. 
Moreover, the doublets appearing at 9.07, 8.67 and 




The compound (2) was synthesized by reacting 
(1) with 4-nitrobenzaldehyde. Yield: 65%; Rf: 0.7 
(dichloromethane:methanol 4:1); m.p.: 274-276 °C; UV-
Vis (DMF) λmax: 305 nm; FT-IR (KBr) ν: 3095, 1683, 
1615, 1597, 1515, 1343, 1246 cm-1, 1H NMR (500 MHz, 
DMSO-d6) δ: 8.56 (s, 1H at C 1), 8.37 (d, J = 8 Hz, 
1H at C 3), 8.07 (d, J = 8 Hz, 1H at C 4), 7.55 (d, J = 
8 Hz, 2H at C 16 and 18), 7.43 (d, J = 8 Hz, 2H at C 
15 and 19), 6.31 (s, 1H at C 20). The first derivative of 
4-hydroxy-6-nitrocoumarin was obtained in good yield 
and considerable melting point range. The 10 nm shift 
in maximum UV/Vis absorbance of the compound from 
4-hydroxy-6-nitrocoumarin as well as the appearance of 
the signal at 1615 cm-1 in FT-IR are the prime evidences 
of the successful synthesis of the compound under 
discussion. Moreover, the disappearance of FT-IR signal 
at 3500 cm-1 along with intense signal appearance at 
1683 cm-1 prove that the hydroxyl group has been 
oxidized to form carbonyl group. In 1HNMR, the 
appearance of singlet at C 20 (6.31 ppm) confirms the 
presence of an exocyclic double bond which is next 
to 4-hydroxy-6-nitrocoumarin. Also the appearance 
of doublets with integration for 2 protons at 7.43 ppm 
and 7.55 ppm verifies the presence of 4-nitrobenzene 
moiety. The rest of the 1HNMR shifts are in line with 
the precursor and prove its integrity. 
(Z)-3-(3-Nitrobenzylidene)-6-nitro-
3H-chromene-2,4-dione (3)
The compound (3) was synthesized by reacting 
(1) with 3-nitrobenzaldehyde. Yield: 60%; Rf: 0.6 
(dichloromethane:methanol 4:1); m.p.: 261-263 °C; UV-
Vis (DMF) λmax: 304 nm; FT-IR (KBr) ν: 1349, 1533, 
1620, 1543, 1249, 1682, 3097 cm-1, 1H NMR (500 MHz, 
DMSO-d6) δ: 8.57 (s, 1H at C 1), 8.37 (d, J = 8 Hz, 1H 
at C 3), 7.65 (d, J = 8 Hz, 1H at C 15), 7.50-7.56 (m, 2H 
at C 4 and 16), 8.03 (d, J = 8 Hz, 1H at C 17), 7.92 (s, 
1H at C 19), 6.32 (s, 1H at C 20). This compound was 
synthesized in 60% yield with acceptable melting point 
range and similar absobance in UV/Vis analysis to (2). 
This compound showed similar FT-IR analysis to (2) as 
well as comparable 1HNMR shifts as far as the integrity 
of 4-hydroxy-6-nitrocoumarin moiety and exocyclic 
double bond formation confirmation are concerned. 
However, in 1HNMR, at C 19 the appearance of singlet 
at 7.92 ppm along with two doublets and one multiplet 
at 7.65, 8.03 and 7.50-7.56 ppm for C 15, C 17 and C16, 
respectively confirms that the C 18 is not attached to 
a proton as there is no proton signal related to C 18. 
Moreover, the downfield shifting of chemical shifts of 
protons at C 15-18 and C 19 can be attributed to the 
presence of a nitrogroup at C 18. This confirms the 




The compound (4) was synthesized by the reaction 
of (1) with 5-flouro-2-hydroxybenzaldehyde. Yield: 
78%; Rf: 0.6 (dichloromethane:methanol 4:1); m.p.: 
291-294 °C; UV-Vis (DMF) λmax: 307; FT-IR (KBr) ν: 
3069, 1716, 1526, 1425, 1340, 1194 cm-1, 1H NMR (400 
MHz, CDCl3) δ: 8.50 (d, J = 4 Hz, 1H at C 1), 8.34 (dd, 
J = 4, 8 Hz, 1H at C 3), 7.56 (d, J = 8 Hz, 1H at C 4), 7.48 
(d, J = 4 Hz, 1H at C 15), 7.35 (dd, J = 4, 8 Hz, 1H at C 
17), 7.21 (d, J = 8 Hz, 1H at C 18), 5.64 (s, 1H at C 19), 
8.06 (s, 1H at C 20). The synthesized compound was in 
good yield as compared to above described compounds. 
The shift in maximum absorbance by 7 nm compared to 
4-hydroxy-6-nitrocoumarin along with the appearance 
of 1621 cm-1 signal in FT-IR spectrum, which determines 
the presence of an exocyclic double bond, are the 
results which point out towards successful synthesis of 
the compound under discussion. An intense signal at 
1194 cm-1 refers to the presence of fluorine in the 
molecule. Furthermore, the remaining vibrations 
recorded in FT-IR spectrum are similar to compound (2) 
which shows that 4-hydroxy-6-nitrocoumarin moiety is 
intact with an exception of the conversion of the hydroxyl 
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group to a carbonyl group. In 1HNMR taken in CDCl3, 
the appearance of singlet at 8.06 ppm refers to the 
presence of olefinic proton, singlet at 5.64 ppm belongs 
to the hydroxyl group, whereas doublets at 7.48 ppm and 
7.21 ppm belong to protons attached to C 15 and C 18, 
respectively. The doublet of doublet appearing at 7.35 
ppm is of the proton attached to C 17. The spectroscopic 




The compound (5) was synthesized by reacting (1) 
with 2-hydroxy-5-methylbenzaldehyde. Yield: 75%; Rf: 
0.6 (dichloromethane:methanol 4:1); m.p.: 272-274 0C; 
UV-Vis (DMF) λmax: 306 nm; FT-IR (KBr) ν: 3125, 
1770, 1650, 1570, 1440, 1325 cm-1. 1H NMR (400 MHz, 
CDCl3) δ:8.48 (d, J = 8 Hz, 1H at C 1), 8.35 (d, J = 8 
Hz, 1H at C 3), 7.48 (d, J = 8 Hz, 1H at C 4), 7.15 (s, 1H 
at C 15), 7.21 (dd, J = 4, 8 Hz, 1H at C 17), 6.95 (d, J = 
8 Hz, 1H at C 18), 11.23 (s, 1H at C 19), 8.67 (s, 1H at C 
20), 2.34 (s, 3H at C 22). The maximum absorption, FT-
IR analysis and 1HNMR spectrum of compound (5) are 
similar to compound (4) with the exception that in FT-
IR, the compound (5) did not show fluorine functionality 
related signal. Moreover, the chemical shifts in 
1HNMR are also in line with the evidences showing 
that the compound under study has successfully been 
synthesized. For instance, singlet at 8.67 ppm shows 
presence of the exocyclic double bond. Moreover, the 
multiplicity and the coupling pattern along with coupling 
constant values in, 1HNMR, prove that the 2-hydroxy-5-
methylbenzaldehyde has successfully been attached via 
a double bond to 4-hydroxy-6-nitrocoumarin moiety.
(Z)-3-(4-Hydroxybenzylidene)-6-nitro-
3H-chromene-2,4-dione (6)
The compound (6) was synthesized by reacting 
(1) with 4-hydroxybenzaldehyde. Yield: 71%; Rf: 0.8 
(dichloromethane:methanol 4:1); m.p.: Above 300 °C 
(decomposed); UV-Vis (DMF) λmax: 306 nm; FT-IR 
(KBr) ν: 3184, 1708, 1620, 1530, 1511, 1342, 1257 cm-1, 
1H NMR (400 MHz, CDCl3) δ: 8.51 (d, J = 8 Hz, 2H 
at C 3), 7.60 (d, J = 8 Hz, 1H at C 4), 5.31 (s, 1H at C 
17), 6.90 (d, J = 8 Hz, 2H at C 6 and 18), 7.11 (d, J = 8 
Hz, 2H at C 15 and 19), 8.95 (s, 1H at C 20). The yield 
of this compound is good, whereas the melting point 
was higher than 300 ºC. The maximum absorbance 
was similar to compound (5) and so were the FT-IR 
vibrations. The presence of an exocyclic double bond 
is evident from the signal appearing at 1620 cm-1. In 
1HNMR, all the signals of 4-hydroxy-6-nitrocoumarin 
moiety were observed along with singlet at 8.95 ppm 
which shows the olefinic proton presence. Also, two 
doublets appearing at 6.90 ppm and 7.11 ppm showed 
the presence two chemically equivalent protons at both 
C 15 and C 19 as well as C 16 and C 18 positions. The 
presence of OH group was confirmed by the appearance 
of singlet at 5.31 ppm. These results prove the successful 
synthesis of compound under discussion.
(Z)-3-(4-Methoxybenzylidene)-6-nitro-
3H-chromene-2,4-dione (7)
This compound (7) was synthesized by the 
reaction of (1) with 4-methoxybenzaldehyde. Yield: 
67%; Rf: 0.6 (dichloromethane:methanol 4:1); m.p.: 
255-257 °C; UV-Vis (DMF) λmax: 304 nm; FT-IR 
(KBr) ν: 3115, 1780, 1640, 1580, 1465, 1325 cm-1,1H 
NMR (400 MHz, CDCl3) δ:8.51 (d, J = 8 Hz, 2H at C 
1 and 3), 6.90 (d, J = 8 Hz, 1H at C 4), 3.83 (s, 3H at C 
17), 7.11 (d, J = 8 Hz, 2H at C 16 and 18), 7.59 (d, J = 8 
Hz, 2H at C 15 and 19), 8.95 (s, 1H at C 20). The yield 
of compound (7) is also appreciable with acceptable 
melting point range and considerable difference in 
maximum absorption. The FT-IR spectrum of this 
compound is similar to compound (6) with stretching 
vibration of exocyclic double bond at 1660 cm-1. In 
case of 1HNMR of this compound, the chemical shifts 
for 4-hydroxy-6-nitrocoumarin moiety are similar to 
previously described compounds, thereby confirming 
the integrity of 4-hydroxy-6-nitrocoumarin moiety 
with the conversion of the hydroxyl group to carbonyl 
group. The synthesis of this compound is evident by 
the signal appearing at 8.95 ppm as singlet which 
belongs to proton attached to olefinic carbon. Similarly, 
the multiplicity and coupling patterns along with 
coupling constants are following the same sequence 
as in compound (6). The signal at 3.83 ppm chemical 
shift is a singlet with integration of 3 protons which 
clearly explains the presence of the methoxy group in 
the molecule. Moreover, the chemical shifts of protons 
attached to C 15, 16, 18 and 19 shifted downfield 
with respect to methoxy group. All these results 
clearly emphasize on the successful synthesis of 
compound (7).
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(Z)-3-(2-Hydroxybenzylidene)-6-nitro-
3H-chromene-2,4-dione (8)
The compound (8) was synthesized by the 
reaction of (1) with 2-hydroxybenzaldehyde. Yield: 
77%; Rf: 0.7 (dichloromethane:methanol 4:1); m.p.: 
294-297 °C; UV-Vis (DMF) λmax: 306 nm, FT-IR 
(KBr) ν: 3072, 1716, 1619, 1526, 1486, 1343, 1221 cm-1, 
1H NMR (400 MHz, CDCl3) δ:8.55 (d, J = 4 Hz, 1H 
at C 1), 8.42 (dd, J = 4, 8 Hz, 1H at C 3), 7.68 (d, J = 8 
Hz, 1H at C 4), 7.50 (d, J = 8 Hz, 1H at C 15), 7.76 (t, J 
= 8 Hz, 1H at C 16), 7.45 (t, J = 8 Hz, 1H at C 17), 7.20 
(d, J = 8 Hz, 1H at C 18), 10.16 (s, 1H at C 19), 8.14 (s, 
1H at C 20). The compound (8) has successfully been 
synthesized in 77% yield and its melting point was 
recorded close to 300 ºC. The maximum absorption 
shift in the UV/Vis analysis along with the presence of 
FT-IR vibration at 1619 cm-1 for alkene functionality 
confirms the synthesis of compound (8). The FT-IR 
vibrations for carbonyl functionality along with nitro 
functionality were present in the molecule, thereby 
confirming that the 4-hydroxy-6-nitrocoumarin part 
of the molecule is present in this molecule as was 
present in the previously synthesized compounds. The 
1HNMR also confirms the synthesis of compound 
(8) in similar fashion as for previous compounds. 
The presence of 2-hydroxybenzaldehyde is confirmed 
by appearance of chemical shift for hydroxyl group 
at 10.16 ppm as a singlet. Moreover, the signals and 
the multiplicity of protons attached to C 15-18 also 
confirms the successful synthesis of compound (8).
(Z)-3-(2-Hydroxy-4-methoxybenzylidene)-
6-nitro-3H-chromene-2,4-dione (9)
The compound (9) was synthesized by reacting (1) 
with 2-hydroxy-4-methoxybenzaldehyde. Yield: 79%; 
Rf: 0.7 (dichloromethane:methanol 4:1); m.p.: 266-268 
°C; UV-Vis (DMF) λmax: 305 nm, FT-IR (KBr) ν: 3124, 
1719, 1623, 1589, 1487, 1343, 1207 cm-1. 1H NMR (400 
MHz, CDCl3) δ:8.48 (d, J = 8 Hz, 1H at C 1), 8.35 (d, 
J = 8 Hz, 1H at C 3), 7.48 (d, J = 8 Hz, 1H at C 4), 6.85 
(d, J = 4 Hz, 1H at C 15), 6.89 (t, J = 4 Hz, 1H at C 16), 
3.89 (s, 1H at C 17), 5.29 (s, 1H at C 18), 12.25 (s, 1H at 
C 19), 8.04 (s, 1H at C 20). 
Overall discussing the methods adopted in order 
to conduct this research, in the first step the nitration 
of 4-hydroxycoumarion was performed as reported 
(Huang et al., 2007). According to the literature, the 
reaction of 4-Hydroxycoumarin with sodium nitrate 
in the presence of sulfuric acid at 0 °C introduces 
the nitro group to the 4-Hydroxycoumarin moiety 
at C 6 and yields the 6-nitro-4-hydroxycouamrin 
(1). In the second step, the compound (1) undergoes 
Knovenegal condition at C 3. The reaction conditions 
were optimized by the reaction of a compound (1) 
with different substituted aromatic aldehydes. The 
ethanol was taken as solvent in the synthesis of all 
compounds (2-9) (Table I). The completion time of 
this second step reaction is largely dependent upon 
the nature of substituents on aromatic aldehydes. The 
reaction completion was monitored on TLC by using 
Dichloromethane : Methanol in (4:1).





2 R = 4-nitrobenzaldehyde 65









6 R = 42-hyroxybenzaldehyde 71
7 R = 4-methoxybenzaldehyde 67





The synthesized compounds (1-9) were characterized 
by using suitable analytical techniques. The λmax of 
compounds (1-9) was measured by making solutions 
of all compounds under study in dichloromethane. The 
absorbance measurements in the UV-Vis region were 
carried out using 10 mm quartz cuvettes. The λmax for 
compound (1) was 315 nm whereas for the compounds 
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(2-9) it’s shifted considerable from 8 nm to 11 nm and 
blue shift was observed as compared to compound (1).
The FT-IR analysis of compound (1) showed two 
characteristic signals at 1340 cm-1 and 1524 cm-1 which 
confirm that the nitro group has been introduced in 
the 4-Hydroxycoumarin moiety. The FT-IR analysis 
of compound (1) gives a broad signal at 3500 cm-1 due 
to the stretching vibration of hydroxyl group present 
at C 4. The FT-IR analysis of compounds (2-9) shows 
the intense signal in the range of 1615 to 1650 cm-1 due 
to the stretching vibrations of aliphatic carbon-carbon 
double bonds which were formed by Knovenegal 
condensation. The disappearance of signal at 
3500 cm-1 along with the appearance of signals either 
at 1682 cm-1 or 1683 cm-1 signifies that the hydroxyl 
group of compound (1) has effectively been converted 
to a carbonyl group.
The 1H NMR spectra of compounds (1-9) are in 
good agreement with the proposed structures. The 1H 
NMR spectrum of compound (1) gives singlet signal 
at δ 5.82 ppm due to the presence of a proton at C 3; 
however, the disappearance of this signal confirms the 
Knovenegal condensation has taken place specifically at 
C 3. The proton at position 14 gives a singlet in the range 
of 8 ppm. 
Antibacterial activity
In antibacterial assay, the ciprofloxacin was used 
as a positive control and it showed 38.5 ± 0.74 mm 
and 33.5 ± 0.77 mm zones of inhibition against S. 
aureus and S. typhimurium, respectively. The DMSO 
was used as negative control in all experiments. 
This negative control showed no zone of inhibition 
against both bacterial strains used in the study. The 
compounds (2), (3) and (8) were found highly active 
as compared to other synthesized compounds as 
they showed antibacterial activity with 26.5 ± 0.84, 
26.0 ± 0.56 and 26.0 ± 0.26 mm zones of inhibition 
against S. aureus, respectively. On the other hand, 
the compound (5) and (9) showed moderate to good 
activity against S. typhimurium as compared to other 
synthesized compounds with 19.5 ± 0.59 and 19.5 ± 
0.32 mm zones of inhibition against S. typhimurium, 
respectively. The antibacterial potential of all the 
synthesized compounds has been summarized in 
(Table II). Therefore, compounds (2), (3) and (8) can 
be considered as potent molecules for developing 
selective antibacterial drugs for S. aureus.
TABLE II - Antibacterial bioassay screening of investigated 
compounds on two selected bacterial strains Staphylococcus 




Zone of inhibition (mm)
Salmonella 
typhimurium
Zone of inhibition 
(mm)
1 21.5 ± 0.57 15.5 ± 0.31
2 26.5 ± 0.84 1.05 ± 0.61
3 26.0 ± 0.56 2.05 ± 0.22
4 18.5 ± 0.81 17.5 ± 0.76
5 24.5 ± 0.25 19.5 ± 0.59
6 1.05 ± 0.77 1.05 ± 0.61
7 21.0 ± 0.22 2.00 ± 0.53
8 26.0 ± 0.26 2.08 ± 0.23
9 20.5 ± 0.51 19.5 ± 0.32
DMSO 0.0 ± 0.0 0.0 ± 0.0 
CPX* 38.5 ± 0.74 33.5 ± 0.77
*CPX=Ciprofloxacin (Standard 8.3 µg of ciprofloxacin in per 
µL DMSO)
Zone of inhibitions are represented as mean ± SEM.
Urease inhibition potential of 
synthesized compounds
The results of urease inhibition revealed that the 
compound (5) showed 38.6% inhibition; whereas, 
compound (2) showed 0.6% inhibition at 0.5 µM 
concentration. During urease inhibition studies thiourea 
was used as a standard and it showed 98.1% inhibition 
at a concentration of 0.5 µM with IC
50
 value 21 ± 0.11. 
However, the compounds (2-9) did not show significant 
% inhibition and, therefore, the IC
50
 values were not 
calculated. The anti-urease activity of all the compounds 
has been summarized in (Table III).
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synthesized compounds were evaluated for their 
antibacterial potential; the compounds (2), (3) and (8) 
showed favorable antibacterial activity, comparable 
to the standard drug (Ciprofloxacin), against 
Staphylococcus aureus whereas the compounds 
(5) and (9) were found active against Salmonella 
typhimurium. Moreover, all the synthesized 
compounds were also evaluated for their possible 
urease and carbonic anhydrase-II inhibition. However, 
none of the synthesized derivatives showed significant 
anti-urease activity. Furthermore, the compounds 
(2) and (6) showed carbonic anhydrase-II inhibition 
activity with IC
50
 values of 263 ± 0.3 and 456 ± 0.1, 
respectively. Therefore, compound (2) is a good 
selective antibacterial agent as well as a good carbonic 
anhydrase-II inhibitor. Compound (3) and (8) are 
also good antibacterial agents and compound (6) is a 
considerably potent carbonic anhydrase-II inhibitor.
Potential carbonic anhydrase-II inhibition 
of synthesized compounds
The carbonic anhydrase-II inhibition assay 
was performed on all synthesized compounds. The 
compounds (2) and (6) showed 63% and 54% inhibition, 
respectively. The IC
50
 values of these compounds were 
263 µM and 456 µM, respectively. The standard taken 
for this study was acetazolamide, which showed 84% 
inhibition at a concentration of 0.5 µM with IC
50
 value 
0.5 ± 0.1. The carbonic anhydrase II activity are shown 
in (Table III). Therefore, the highest % inhibition was 
shown by compound (2) which can be considered as a 
potential drug candidate for inhibiting the activity of 
carbonic anhydrase-II.
CONCLUSION
In this study, the successful synthesis and 
characterization of 4-hydroxy-6-nitrocoumarin was 
carried out along with its eight derivatives. All these 
























1 - - - - - 22.4 -
2 H H NO
2
H H 0.6 63 263 ± 0.3
3 H NO
2
H H H 26.7 -
4 OH H H F H 17.2 -
5 OH H H CH
3
H 38.6 -
6 H H OH H H 27.9 54 456 ± 0.1
7 H H OCH
3
H H 20.0 -
8 OH H H H H 16.7 -
9 OH H OCH
3
H H 16.1 -
Standard (thiourea for urease inhibition) 98.1 21 ± 0.11
Standard (acetazolamide for CA II inhibition) 84 0.5 ± 0.1
Enzyme inhibition and antibacterial potential of 4-hydroxycoumarin derivatives
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